Levofloxacin
Product Images NDC 0409-0528

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 0409-0528). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Levofloxacin 01)

Chemical structure of the active ingredient Levofloxacin, showing its molecular arrangement including a fluorine atom, carboxyl group, and a methyl group.*

FDA Label Image

Figure 2 (Levofloxacin 02)

A line graph showing mean Levofloxacin plasma concentration over time comparing 750 mg tablet oral and 750 mg intravenous (90 minute infusion) doses. The y-axis represents plasma concentration (mcg/mL) and the x-axis represents time in hours up to 36 hours, illustrating pharmacokinetic profiles of both administration routes.*

FDA Label Image

Figure 3 (Levofloxacin 03)

Line chart showing mean Levofloxacin plasma concentration (mcg/mL) over time (hours) comparing 500 mg tablet oral administration and 500 mg intravenous administration. The graph illustrates plasma concentration peaks shortly after dosing and declines over 36 hours for both forms.*

FDA Label Image

Logo (Levofloxacin 04)

FDA Label Image

Logo (Levofloxacin 05)

FDA Label Image

Principal Display Panel (50 mL Bag Label)

Label for LEVOFLOXACIN 250 mg/50 mL (5 mg/mL) in 5% Dextrose Injection, 50 mL intravenous solution. Distributed by Hospira, Inc., the label includes usage instructions, ingredient details, and warnings. The product is a clear, single-use container intended for infusion over 60 minutes and should be used immediately once removed from overwrap.*

FDA Label Image

Principal Display Panel (50 mL Bag Pouch)

Label for LEVOFLOXACIN in 5% Dextrose Injection, 250 mg/50 mL (5 mg/mL), a 50 mL intravenous infusion solution. The label includes dosing information, storage instructions, and a barcode. It is distributed by Hospira, Inc., Lake Forest, IL, USA, and includes instructions for use and precautions for pharmacists.*

FDA Label Image

Principal Display Panel (100 mL Bag Label)

Label for Levofloxacin in 5% Dextrose Injection, 500 mg/100 mL (5 mg/mL) in a 100 mL single-dose intravenous infusion bag. The label states the solution contains 500 mg levofloxacin in 100 mL 5% dextrose, distributed by Hospira, Inc., and includes handling and usage instructions. The label also notes the container is free of natural rubber latex and contains DEHP plasticizer.*

FDA Label Image

Principal Display Panel (100 mL Bag Pouch)

LEVOFLOXACIN 500 mg/100 mL (5 mg/mL) in 5% Dextrose Injection, 100 mL IV infusion bag. Label includes dosage and infusion instructions, pharmacist warning, storage conditions, and manufacturer Hospira, Inc. The label features a barcode and instructions to infuse over 60 minutes for intravenous use.*

FDA Label Image

Principal Display Panel (150 mL Bag Label)

Label for LEVOFLOXACIN intravenous injection in 5% Dextrose, 750 mg per 150 mL (5 mg/mL), distributed by Hospira, Inc. The label includes dosing concentration, storage and usage instructions, and manufacturer information. The label also has areas marked for lot number and expiration date, with the product contained in a 150 mL single-use container.*

FDA Label Image

Principal Display Panel (150 mL Bag Pouch)

Levofloxacin in 5% Dextrose Injection, 750 mg per 150 mL (5 mg/mL) intravenous infusion by Hospira, Inc. The label includes drug concentration, volume, instructions for use, storage conditions, and warnings. It features barcode, unit NDC 0409-0528-31, and directions to infuse over 90 minutes. The label also emphasizes leaving the bag in the overwrap until use and contains regulatory and handling information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.